Overview

Clinical Study of Tumor Treating Fields Combined With Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer

Status:
Not yet recruiting

Trial end date:
2027-09-28

Target enrollment:

Participant gender:

Summary

The Objectives of this clinical trial is to evaluate the efficacy and safety of tumor treating fields combined with gemcitabine and albumin bound paclitaxel in the treatment of locally advanced pancreatic cancer.

Phase:

Phase 3

Details

Lead Sponsor:

Jiangsu Healthy Life Innovation Medical Technology Co., Ltd

Treatments:

Albumin-Bound Paclitaxel
Gemcitabine
Paclitaxel